Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine

Background: Hyperhomocysteinemia and lipid abnormalities are commonly found in patients with chronic renal failure; both are recognized as risk factors for atherosclerosis. The homocysteine-lowering effect of pyridoxine is controversial. This study was performed to determine the effect of a high dos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tacconi de Gómez Dumm, Irma Nelva, Giammona, Ana María, Touceda, Luis Alberto
Formato: Articulo
Lenguaje:Inglés
Publicado: 2003
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/37014
http://www.lipidworld.com/content/pdf/1476-511X-2-7.pdf
Aporte de:
id I19-R120-10915-37014
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Ciencias Exactas
Ciencias Médicas
homocysteine
membrane phospholipid
pyridoxine
triacylglycerol
amino acid blood level
Anisotropía
cell membrane fluidity
erythrocyte membrane
spellingShingle Ciencias Exactas
Ciencias Médicas
homocysteine
membrane phospholipid
pyridoxine
triacylglycerol
amino acid blood level
Anisotropía
cell membrane fluidity
erythrocyte membrane
Tacconi de Gómez Dumm, Irma Nelva
Giammona, Ana María
Touceda, Luis Alberto
Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
topic_facet Ciencias Exactas
Ciencias Médicas
homocysteine
membrane phospholipid
pyridoxine
triacylglycerol
amino acid blood level
Anisotropía
cell membrane fluidity
erythrocyte membrane
description Background: Hyperhomocysteinemia and lipid abnormalities are commonly found in patients with chronic renal failure; both are recognized as risk factors for atherosclerosis. The homocysteine-lowering effect of pyridoxine is controversial. This study was performed to determine the effect of a high dose of pyridoxine (300 mg i.v. three times a week) on plasma and red blood cell lipid profile and plasma homocysteine concentration in twelve chronic renal failure patients on regular hemodialysis. Fasting blood samples were taken at the beginning of the study (basal 1), after 30 and 60 days of treatment and 4 months after withdrawal (basal 2). Results: Pyridoxine supplementation induced a significant decrease in total plasma homocysteine level and also a lowering effect in plasma total cholesterol and triglycerides. These biochemical data increased when the samples were taken at basal 2, reaching the levels obtained at the beginning of the experiment. LDL cholesterol increased whereas HDL cholesterol was reduced during the treatment. In erythrocyte membranes vitamin B6 therapy enhanced the cholesterol/phospholipid ratio as well as the fluorescence anisotropy of diphenyl-hexatriene. Conclusions: We conclude that high doses of pyridoxine represent an effective strategy to ameliorate both plasma homocysteine levels and lipid profiles in chronic renal failure patients, protecting them from atherosclerosis. Further research using a long-term treatment would be necessary in an attempt to restore the fatty acid pattern and the fluidity of red cell membranes.
format Articulo
Articulo
author Tacconi de Gómez Dumm, Irma Nelva
Giammona, Ana María
Touceda, Luis Alberto
author_facet Tacconi de Gómez Dumm, Irma Nelva
Giammona, Ana María
Touceda, Luis Alberto
author_sort Tacconi de Gómez Dumm, Irma Nelva
title Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
title_short Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
title_full Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
title_fullStr Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
title_full_unstemmed Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
title_sort variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
publishDate 2003
url http://sedici.unlp.edu.ar/handle/10915/37014
http://www.lipidworld.com/content/pdf/1476-511X-2-7.pdf
work_keys_str_mv AT tacconidegomezdummirmanelva variationsinthelipidprofileofpatientswithchronicrenalfailuretreatedwithpyridoxine
AT giammonaanamaria variationsinthelipidprofileofpatientswithchronicrenalfailuretreatedwithpyridoxine
AT toucedaluisalberto variationsinthelipidprofileofpatientswithchronicrenalfailuretreatedwithpyridoxine
bdutipo_str Repositorios
_version_ 1764820472397037569